Global Dementia Legacy Event: John Ryan
Upcoming SlideShare
Loading in...5
×
 

Global Dementia Legacy Event: John Ryan

on

  • 638 views

Session Two: Barriers to investment in research to find a disease modifying therapy or cure for dementia.

Session Two: Barriers to investment in research to find a disease modifying therapy or cure for dementia.

John Ryan, Acting Director of the European Commission Public Health Directorate

Statistics

Views

Total Views
638
Views on SlideShare
72
Embed Views
566

Actions

Likes
0
Downloads
4
Comments
0

2 Embeds 566

http://dementiachallenge.dh.gov.uk 561
https://dementiachallenge.dh.gov.uk 5

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Global Dementia Legacy Event: John Ryan Global Dementia Legacy Event: John Ryan Presentation Transcript

  • Global Action on Dementia Legacy Event Session "Barriers to investment in dementia treatment research" 19 June 2014 John F. Ryan Director Public Health Health and Consumers Directorate General European Commission
  • EU-level health policy actions on dementia Strategic Framework: •Commission Communication “EU-initiative on Alzheimer’s disease and other dementias” of 2009 (COM (2009) 380 final) •Implementation report expected for July 2014 To be reported, i.a.: •Joint Action ALCOVE (2011-2013) led by France; •Context of EU-work on chronic disorders; •European Innovation Partnership Active and Healthy Ageing; •Conference "Health in Europe. Making it fairer", March 2014
  • (Million EUR) EU Seventh Framework Programme for Research: support to neurodegenerative diseases research FP7
  • • - Understanding health, ageing and disease: determinants, risk factors and pathways • - New therapies for chronic non-communicable diseases • - Comparing the effectiveness of existing healthcare interventions in the elderly • - ERA-NET: Establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 • - Development of new diagnostic tools and technologies: in vivo medical imaging technologies • - Tools and technologies for advanced therapies Societal Challenge "Health, Demographic Change and Wellbeing" Call "Personalising health and care" (2014-2015) Some topics relevant for dementia research Horizon 2020 (2014-2020)
  • Courtesy of A. Maggi (JPND) JPND
  • JPND Achievements  - € 68,5 million for transnational calls (2011-2014), 15 projects ongoing (2011-2012; 2013-2014 call: projects selection on-going)  - mapping national and European research and infrastructures relevant to neurodegenerative diseases: searchable public database Globalisation – third countries  - Participation of Canada  - Discussions with the USA started  - Involved in the OECD follow-up activities of the G8 on dementia EU support to JPND  - FP7 Coordination Action Jumpahead (until August 2014)  - H2020 – WP 2014: ERA-Net: Joint Programming - Establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 (peer-review ongoing)
  • JPND Achievements  - € 68,5 million for transnational calls (2011-2014), 15 projects ongoing (2011-2012; 2013-2014 call: projects selection on-going)  - mapping national and European research and infrastructures relevant to neurodegenerative diseases: searchable public database Globalisation – third countries  - Participation of Canada  - Discussions with the USA started  - Involved in the OECD follow-up activities of the G8 on dementia EU support to JPND  - FP7 Coordination Action Jumpahead (until August 2014)  - H2020 – WP 2014: ERA-Net: Joint Programming - Establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 (peer-review ongoing)